ALNY
Price
$400.59
Change
-$0.10 (-0.02%)
Updated
Dec 26 closing price
Capitalization
52.92B
47 days until earnings call
Intraday BUY SELL Signals
ATHA
Price
$7.48
Change
+$0.27 (+3.74%)
Updated
Dec 26 closing price
Capitalization
29.5M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALNY vs ATHA

Header iconALNY vs ATHA Comparison
Open Charts ALNY vs ATHABanner chart's image
Alnylam Pharmaceuticals
Price$400.59
Change-$0.10 (-0.02%)
Volume$401.46K
Capitalization52.92B
Athira Pharma
Price$7.48
Change+$0.27 (+3.74%)
Volume$139.52K
Capitalization29.5M
ALNY vs ATHA Comparison Chart in %
ALNY
Daily Signal:
Gain/Loss:
ATHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALNY vs. ATHA commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and ATHA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (ALNY: $400.59 vs. ATHA: $7.48)
Brand notoriety: ALNY and ATHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 30% vs. ATHA: 10%
Market capitalization -- ALNY: $52.92B vs. ATHA: $29.5M
ALNY [@Biotechnology] is valued at $52.92B. ATHA’s [@Biotechnology] market capitalization is $29.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 2 FA rating(s) are green whileATHA’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 2 green, 3 red.
  • ATHA’s FA Score: 1 green, 4 red.
According to our system of comparison, ALNY is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ATHA’s TA Score has 6 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • ATHA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а +0.09% price change this week, while ATHA (@Biotechnology) price change was +7.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($52.9B) has a higher market cap than ATHA($29.5M). ALNY YTD gains are higher at: 70.239 vs. ATHA (27.493). ALNY has higher annual earnings (EBITDA): 187M vs. ATHA (-38.3M). ALNY has more cash in the bank: 2.73B vs. ATHA (25.2M). ATHA has less debt than ALNY: ATHA (912K) vs ALNY (1.31B). ALNY has higher revenues than ATHA: ALNY (3.21B) vs ATHA (0).
ALNYATHAALNY / ATHA
Capitalization52.9B29.5M179,322%
EBITDA187M-38.3M-488%
Gain YTD70.23927.493255%
P/E Ratio1335.30N/A-
Revenue3.21B0-
Total Cash2.73B25.2M10,813%
Total Debt1.31B912K143,421%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYATHA
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
64%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signal:
Gain/Loss:
ATHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TFPN26.170.04
+0.13%
Blueprint Chesapeake Multi-Asst Trnd ETF
VGM10.320.01
+0.10%
Invesco Trust Investment Grade Municipals
XIJN31.000.03
+0.10%
FT Vest U.S. Eq Bffr & Prm Inc ETF -June
URTH187.810.09
+0.05%
iShares MSCI World ETF
FXBY23.25-0.55
-2.31%
Foxby Corp.

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with ARGX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.02%
ARGX - ALNY
52%
Loosely correlated
-0.59%
SGMO - ALNY
42%
Loosely correlated
-4.49%
IONS - ALNY
37%
Loosely correlated
-0.89%
ALLO - ALNY
37%
Loosely correlated
-1.43%
BBIO - ALNY
36%
Loosely correlated
-0.95%
More

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with ALNY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+3.74%
ALNY - ATHA
35%
Loosely correlated
-0.02%
OGEN - ATHA
35%
Loosely correlated
+2.86%
NAGE - ATHA
34%
Loosely correlated
+0.45%
IPSC - ATHA
33%
Loosely correlated
+4.33%
MNKD - ATHA
32%
Poorly correlated
-2.36%
More